January 16, 2013 |
BUFFALO, N.Y. - Federal authorities warned against the infection risks of using insulin pens on more than one patient, and officials on Monday asked why a Buffalo veterans hospital may have used the pens on many patients, causing an HIV scare. More than 700 patients admitted to the Veterans Affairs Western New York Healthcare System over a two-year period may have been exposed to HIV, hepatitis B and hepatitis C, officials said following a review that found that multi-dose pens intended for use by a single patient may have been used on more than one person.
October 23, 2012 |
Peter Hopkins, the music director at St. Peter's Church, is an erudite, energetic man who plays the piano and organ, sings with a fine tenor voice, and can blend the disparate voices in the choir so that hymns fill the historic Episcopal church in Society Hill with a sound that's upliftingly supernal. Physically, he looks lean and fit, carrying 180 pounds on a 5-foot-11 frame. If you met him today, you'd never believe that he once weighed 300 pounds. But such were the wages of sin in his youth.
August 11, 2012 |
A half-dozen medical students crowd into a lab at Jefferson Medical College as Jeffrey Joseph points to a graph of a patient's blood sugar. While healthy levels stay within a narrow range, this man's pattern is wildly erratic, peaking at four times the normal amount after a meal and plunging dangerously low during sleep. The graphs are from a diabetic named Brian who had his blood sugar, or glucose, continuously monitored over three days for a study, says Joseph, head of Jefferson's Artificial Pancreas Center.
June 9, 2012 |
What used to be called "adult-onset diabetes" — a leading cause of kidney failure, limb amputations, blindness, heart disease, and stroke among adults — is now a growing problem for American children, too. This health challenge, and how to deal with it, will be one of the hottest topics at this weekend's American Diabetes Association conference. An expected 16,000 health professionals, researchers, advocates, and vendors from around the world are gathering at the Convention Center to share the latest in diabetes research.
May 17, 2012 |
An $80 million national research plan to attack Alzheimer's, a mind-robbing malady that may affect as many as 16 million Americans by 2050, will start this year with U.S.-sponsored studies on ways to prevent the disease in high-risk people and treat it with an insulin nasal spray. The National Institutes of Health will spend $7.9 million researching the spray and $16 million on the first study to focus on growth of the disease in high-risk patients, according to a statement today by Department of Health and Human Services.
April 29, 2012 |
The number of diabetics in America is growing. The number of unemployed pharmaceutical workers seems to be doing the same. That combination is bad, unless you are Novo Nordisk. A relatively small Danish-based drug company with a U.S. home in Princeton, Novo Nordisk is in a sweet spot in the pharmaceutical landscape because the core of its business is diabetes. With 40 straight quarters of double-digit growth, the company said Friday it plans a 15 percent increase to its U.S. workforce, meaning about 615 more jobs, through the end of this year.
April 9, 2012 |
Several large studies have shown that people with diabetes are at especially high risk for Alzheimer's disease. Steven Arnold, director of the University of Pennsylvania's Memory Center, said diabetics are 50 to 100 percent more likely to get the fatal, memory-destroying disease. This has made researchers increasingly interested in the role that insulin, the hormone that's out of whack in diabetes, might play in Alzheimer's. In the brain, Arnold said, insulin is important for cell growth and releasing neurotransmitters that allow cells to communicate.
March 14, 2012
In the Region Pfizer, Biocon scrap accord Drugmakers Pfizer and Biocon are calling off an agreement to both sell Biocon's insulin and the generic version of several insulin products. The companies say the individual priorities of their so-called biosimilars businesses made them decide to move forward independently. Biosimilars are medicines similar to biologic drugs but are not identical in the way that generic drugs are copies of brand-name pills. Biologic drugs are complex injected drugs manufactured from living cells rather than by mixing chemical compounds together and turning them into pills.
February 10, 2012
IT IS VERY unfortunate that Philadelphia has decided to reduce the number of school nurses. All children benefit from the expertise provided by the school nurse. However, for the child with diabetes, a number of other caregivers can be trained to administer insulin and to recognize and treat low blood sugar. Parents of newly diagnosed children with diabetes quickly learn to care for their child. They also train others, such as family members and babysitters, to provide care. And, of course, older children can usually administer their own insulin.
January 10, 2012
Johnson & Johnson's Animas unit kept selling insulin pumps last year after learning of malfunctions with the devices that prompted it to make design changes, the Food and Drug Administration said. The agency faulted the J&J unit, based in West Chester, for not adequately explaining "why your firm continued to manufacture insulin pumps" after they "had known failures. " The issues with Animas' OneTouch Ping and 2020 pumps prompted a company investigation that started in April 2011, according to the FDA's letter.